Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2021-08-27 2021-08-27
Drug Identification Number 02465949 02465949
Brand name TEVA-BUDESONIDE TEVA-BUDESONIDE
Common or Proper name BUDESONIDE INH 0.125MG/ML 2ML BUDESONIDE INH 0.125MG/ML 2ML
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients BUDESONIDE BUDESONIDE
Strength(s) 0.125MG 0.125MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 20pk 20pk
ATC code R03BA R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-06-02 2021-06-02
Estimated end date 2021-09-30 2021-09-30
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments